Modulation of the Urea Cycle through the Combined Use of SGLT2 Inhibitors and Metformin - Top-Institutions - MDSpire

Modulation of the Urea Cycle through the Combined Use of SGLT2 Inhibitors and Metformin

  • By

  • Makoto Harada

  • Jonathan Adam

  • Siyu Han

  • Mengya Shi

  • Jianhong Ge

  • Jutta Lintelmann

  • Alexander Cecil

  • Sven Zukunft

  • Cornelia Prehn

  • Michael Witting

  • Markus F. Scheerer

  • Susanne Neschen

  • Martin Irmler

  • Johannes Beckers

  • Jerzy Adamski

  • Daniel Teupser

  • Birgit Linkohr

  • Christian Gieger

  • Martin Hrabě de Angelis

  • Annette Peters

  • Rui Wang-Sattler

  • January 8, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Joslin Diabetes Center
    Joslin Diabetes Center

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Diabetes Research
    • Metabolomics

  • #2

    Massachusetts General Hospital (MGH) Diabetes Unit
    Massachusetts General Hospital (MGH) Diabetes Unit

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Metabolic Disease
    • Clinical Pharmacology

  • #3

    University of California, San Francisco (UCSF) Diabetes Center
    University of California, San Francisco (UCSF) Diabetes Center

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Metabolomics
    • Diabetes Research

  • #4

    Helmholtz Zentrum München - German Research Center for Environmental Health
    Helmholtz Zentrum München - German Research Center for Environmental Health

    Neuherberg, Bavaria

    Key Differentiators

    • Metabolomics
    • Diabetes Research
    • Systems Biology

  • #5

    University of Cambridge Metabolic Research Laboratories
    University of Cambridge Metabolic Research Laboratories

    Cambridge, England

    Key Differentiators

    • Endocrinology
    • Metabolomics
    • Diabetes

Original Source(s)

Modulation of the Urea Cycle through the Combined Use of SGLT2 Inhibitors and Metformin

  • by Makoto Harada, Jonathan Adam, Siyu Han, Mengya Shi, Jianhong Ge, Jutta Lintelmann, Alexander Cecil, Sven Zukunft, Cornelia Prehn, Michael Witting, Markus F. Scheerer, Susanne Neschen, Martin Irmler, Johannes Beckers, Jerzy Adamski, Daniel Teupser, Birgit Linkohr, Christian Gieger, Martin Hrabě de Angelis, Annette Peters, Rui Wang-Sattler

  • January 8, 2026

Related Content

The correlation between the trajectory of plasma atherosclerosis-inducing index in the examination population and the risk of developing metabolic dysfunction-associated steatotic liver disease

Diabetes Mellitus Coding in Retina

Age-related macular degeneration (AMD) is among the most common retinal diagnoses. Although the clinical features of the disease are well known, ICD-10 coding can be confusing if details such as stage, activity, and laterality are not clearly documented. Incomplete documentation may prompt questions about the medical necessity of diagnostic tests or intravitreal injections. This Q&A addresses common sources of confusion and offers practical guidance to support clear, accurate documentation.

Special Series eBook: GLP-1 Analysis

Experts explore how analytical science is meeting the challenges shaping GLP-1 therapeutics

  • April 14, 2026

  • 1 min